[Controlled trial of flurbiprofen (platelet anti-aggregant) in the secondary prevention of atherosclerotic cerebral infarcts].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002544:Cerebral Infarction / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005260:Female; D005480:Flurbiprofen / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D011422:Propionates / Q000627:therapeutic use*
D011422:Propionates; D005480:Flurbiprofen
Essai contrôlé du flurbiprofène (anti-agrégant plaquettaire) dans la prévention secondaire des infarctus cérébraux de l'athérosclérose.